# Tom Schwarz

> Tom Schwarz is a startup investor at Innovation Industries (Bilthoven). See 0 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Innovation Industries](https://shizune.co/investors/profile/innovation-industries)
- Location: Bilthoven, The Netherlands
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/tom-schwarz-283a57111/

Tom Schwarz is a startup investor at Innovation Industries in Bilthoven. Tom Schwarz, partner, possesses seed and early stage investment and corporate experience. Tom was co-founder, general partner of Life Sciences Partners, a biotech venture capital fund with offices in Amsterdam, Munich and Boston, where he focused on early stage investments in the Benelux. Tom has served on the supervisory boards of many biotechcompanies and is a board member for Biopartner Start-up Ventures, and a former member of the EVCA High Tech Committee. In 1997, Tom sold U-Gene Research, a company he spun-out of the University of Utrecht, to Kendle, a leading US clinical research organization. Tom started his career at Interpharm, one of the largest pharmaceutical wholesalers in the Netherlands. He was trained as a pharmacist at the University of Utrecht.

## About Innovation Industries

VC Fund · Amsterdam, The Netherlands

Innovation Industries is a venture capital firm that invests in hightech, medtech and agri-foodtech companies in The NetherlandsInnovation Industries maintains a hands-on management style, sharing its experience, knowledge and connections with the entrepreneurs. Portfolio companies are actively supported in order to strengthen the valueproposition, improve the time-to- market, identify and realize global strategic partnerships and avoid the typical start-up pitfalls. Innovation Industries sees itself as a partner of the entrepreneurs and the other parties involved; a creator of ventures, rather than merely a financial investor.Innovation Industries focuses primarily on start-ups but will also be able to invest into scale-ups. With this relatively broad spectrum of funding capabilities, emerging breakthroughs in research and technology can be sustained by sufficient venture capital to optimize their chances of success and ultimately provide returns to the Fund’s investors. Once these companies are established with seed funding, the Fund will be able to continue financing the advancement of these businesses and technologies.

5 contacts available at Innovation Industries.

| Name | Title | Profile |
| --- | --- | --- |
| Chris Sonnenberg | General Partner | https://shizune.co/investors/profile/chris-sonnenberg |
| Harm de Vries | Co-founder and General Partner | https://shizune.co/investors/profile/harm-de-vries |
| Nard Sintenie | General Partner | https://shizune.co/investors/profile/nard-sintenie |
| Tom Schwarz | Partner | https://shizune.co/investors/profile/tom-schwarz |
| Tom van Vuren | Investment Director | https://shizune.co/investors/profile/tom-van-vuren-vuren |

## FAQ

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co